Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

7.43
Delayed Data
As of 4:00pm ET
 -0.03 / -0.40%
Today’s Change
6.17
Today|||52-Week Range
11.93
-9.39%
Year-to-Date
No recent news for Avadel Pharmaceuticals PLC.

Today’s Trading

Previous close7.46
Today’s open7.46
Day’s range7.27 - 7.50
Volume137,184
Average volume (3 months)492,921
Market cap$257.9M
Data as of 4:00pm ET, 06/19/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-541.94%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)+16.60%
P/E ratio10.6
Price/Sales1.96
Price/Book3.23

Competitors

 Today’s
change
Today’s
% change
IOVAIovance Biotherapeut...+0.10+0.75%
GLYCGlycoMimetics Inc+0.10+0.65%
TLGTTeligent Inc+0.01+0.27%
DEPODepomed Inc+0.03+0.42%
Data as of 4:00pm ET, 06/19/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$174.7M
Annual profit (last year)$68.8M
Net profit margin39.41%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Michael Shannon Anderson
Chief Operating Officer &
Executive Vice President
Gregory J. Divis
Corporate headquarters
Dublin, Dublin

Forecasts